Botanical species · safety record

Roemeria hybrida

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Roemeria hybrida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Roemeria hybrida (L.) DC.

7Constituent measurements
1Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids3
  • Aporphine alkaloids2
  • Isoquinoline alkaloids2

Plant parts

  • Live plants5
  • Aerial part of plants2
  • Unspecified1

Preparations

  • Solvent extraction7

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Aporphine alkaloidsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Aporphine alkaloidsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Isoquinoline alkaloidsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Isoquinoline alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveLive plantsHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Gunes, HS., Gozler, B. Two novel proaporphine-tryptamine dimers from Roemeria hybrida. Fitoterapia, 2001, vol. 72, no. 8, p. 875-886. DOI
  2. El-Masry, Sawsan., Amer, Masouda., Ghazy, Nabila M., El-Lakany, Abdalla M. Alkaloids from Roemeria hybrida L. growing in Egypt. Alexandria journal of pharmaceutical sciences, 1990, vol. 4, no. 1, p. 90-3.
  3. Al-Qura'n, S. Ethnobotanical survey of folk toxic plants in southern part of Jordan. Toxicon, 2005, vol. 46, no. 2, p. 119-129. DOI
  4. GOZLER, B., SHAMMA, M. 4 BETA-CARBOLINE ALKALOIDS FROM ROEMERIA-HYBRIDA. Journal of natural products, 1990, vol. 53, no. 3, p. 740-743. DOI
  5. GOZLER, B., FREYER, AJ., SHAMMA, M. THE 10 PROAPORPHINE-TRYPTAMINE DIMERS. Journal of natural products, 1990, vol. 53, no. 3, p. 675-685. DOI
  6. Ebrahimi, Samad Nejad., Bagheri-Zomorrodi, Zahra., Shakeri, Abolfazl., Iranshahy, Milad., Masullo, Milena., Piacente, Sonia., Iranshahi, Mehrdad. The Absolute Configuration and Cytotoxic Properties of Roehybridine beta-N-oxide . Natural product communications, 2016, vol. 11, no. 12, p. 1813-1816.
  7. GOZLER, B., GOZLER, T., METE, IE., FREYER, AJ., GUINAUDEAU, H., SHAMMA, M. NEW PROAPORPHINE ALKALOIDS FROM ROEMERIA-HYBRIDA. Tetrahedron, 1987, vol. 43, no. 8, p. 1765-1770. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue